Fulminant Eosinophilic Myocarditis in a Young Adult: Successful Recovery After Extracorporeal Membrane Oxygenation (ECMO) Support and Multisystem Complications

青年成人暴发性嗜酸性粒细胞性心肌炎:体外膜肺氧合(ECMO)支持后成功康复及多系统并发症

阅读:2

Abstract

Eosinophilic myocarditis (EM) is a rare inflammatory cardiomyopathy with a highly variable clinical presentation, ranging from mild symptoms to fulminant cardiogenic shock. Its diagnosis is challenging due to non-specific clinical findings and requires a high index of suspicion, with endomyocardial biopsy (EMB) serving as the gold standard. Early initiation of immunosuppressive therapy and, in severe cases, mechanical circulatory support (MCS) are essential to improve outcomes. We report the case of a 21-year-old male who presented with progressive dyspnea, chest pain, and hypoxemia. Echocardiography revealed severe left ventricular dysfunction. Coronary angiography excluded obstructive disease, while EMB confirmed EM. Due to cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (ECMO) was implanted on the day of admission. High-dose corticosteroids and azathioprine were initiated, leading to gradual improvement of ventricular function and subsequent ECMO explantation. The course was complicated by left ventricular thrombus formation, which resolved under systemic anticoagulation, and by ischemic colitis requiring right hemicolectomy with ileostomy. Following tracheostomy and prolonged weaning, the patient achieved functional recovery and was discharged on immunosuppressive and anticoagulant therapy. Six months later, surgical restoration of bowel continuity was performed without complications. Follow-up echocardiography demonstrated recovery of left ventricular ejection fraction (LVEF) to 50%, with no evidence of thrombus recurrence. This case highlights the diagnostic and therapeutic challenges of EM, including its fulminant presentation, life-threatening complications, and the critical role of multidisciplinary management. Prompt recognition, biopsy-guided diagnosis, early immunosuppression, MCS when indicated, and careful monitoring for systemic complications can lead to favorable outcomes, even in complex and prolonged clinical courses.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。